LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Akcijų sąrašas・NeoGenomics Inc

NeoGenomics Inc

Uždarymo kaina

8.23 -1.08

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.19

Max

8.32

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-7.2M -17M
Pardavimai	-3.5M 187M
Pelnas, tenkantis vienai akcijai	0.01
Pelno marža	-9.164
Darbuotojai	2,500
EBITDA	-5.8M -567K

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+80.87% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-07-28

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	7.1M 1.1B
Ankstesnė atidarymo kaina	9.31
Ankstesnė uždarymo kaina	8.23

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

7.7 / 10.27 Palaikymas ir pasipriešinimas

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-05-15 16:02; UTC

Uždarbis

Pagrindinės rinkos jėgos

Forward Industries Shares Fall on New Debt as Solana Value Drops

2026-05-15 03:37; UTC

Įsigijimai, susijungimai, perėmimai

Hana Bank to Buy $670 Million Stake in Crypto Exchange Operator Dunamu

2026-05-12 14:22; UTC

Pagrindinės rinkos jėgos

Coincheck Shares Rise on $65 Million KDDI Investment, Digital-Asset Alliance

2026-05-15 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-15 13:19; UTC

Rinkos pokalbiai

Bitcoin Hits Resistance Despite Clarity Act Progress -- Market Talk

2026-05-15 12:49; UTC

Rinkos pokalbiai

Bitcoin Falls on Risk Aversion, Stronger Dollar -- Market Talk

2026-05-15 08:47; UTC

Rinkos pokalbiai

Bitcoin Falls on Iran War Tensions, U.S. Rate-Rise Bets -- Market Talk

2026-05-14 23:57; UTC

Įsigijimai, susijungimai, perėmimai

Kakao: Stake Sales Aim to Secure Funds for Future Investments

2026-05-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Kakao: Share Sale to Lower Kakao Investment's Stake in Dunmau to 4.03%

2026-05-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Kakao: Affiliate Kakao Investment to Sell 2.3M Dunamu Shares on June 15

2026-05-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Kakao to Sell 6.55% Stake in Crypto Exchange Operator Dunamu to Hana Financial for KRW1.003T

2026-05-14 17:13; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-05-14 17:13; UTC

Rinkos pokalbiai

Higher Interest Rates for Longer Seen Positive for Stablecoins -- Market Talk

2026-05-14 14:43; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-05-14 14:43; UTC

Rinkos pokalbiai

Bitcoin Stabilizes After $630M ETF Outflow -- Market Talk

2026-05-14 11:48; UTC

Rinkos pokalbiai

Bitcoin Turns Slightly Lower Amid Inflation Concerns, Iran War -- Market Talk

2026-05-14 07:25; UTC

Rinkos pokalbiai

Bitcoin Edges Higher But Recovery Limited -- Market Talk

2026-05-13 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-13 16:58; UTC

Rinkos pokalbiai

Change to Ethereum Staking Could Boost Prices, Says Grayscale -- Market Talk

2026-05-13 16:53; UTC

Rinkos pokalbiai

Bitcoin Retreats to Short-Term Resistance Levels -- Market Talk

2026-05-13 15:37; UTC

Rinkos pokalbiai

Bitcoin Moves Back Under $80K as Crypto Caution Remains -- Market Talk

2026-05-13 12:51; UTC

Rinkos pokalbiai

Bitcoin Turns Lower as Trump-Xi Meeting Eyed -- Market Talk

2026-05-13 07:44; UTC

Rinkos pokalbiai

Bitcoin Rises But Middle East Tensions Limit Gains -- Market Talk

2026-05-13 07:44; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-05-12 20:35; UTC

Uždarbis

Fold Holdings: 1Q Total Verified Accounts Nearly 85,000, Added Close to 2,000 New Verified Accounts >FLD

2026-05-12 20:35; UTC

Uždarbis

Fold Holdings: 1Q Total Transaction Volume: $172M; 32% YoY Decrease >FLD

2026-05-12 20:34; UTC

Uždarbis

Fold Holdings: More Than 1,000 Fold Bitcoin Credit Cards in Circulation >FLD

2026-05-12 20:34; UTC

Uždarbis

Fold Holdings: Transaction Volumes Dn 32% YoY >FLD

2026-05-12 20:34; UTC

Uždarbis

Fold Holdings: Restructuring Fees on Bitcoin Gift Card to Drive Distribution >FLD

2026-05-12 17:25; UTC

Uždarbis

EToro Reports Sharp Drop in Crypto Trading. The Stock Falls. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

80.87% į viršų

12 mėnesių prognozė

Vidutinis 14.94 USD 80.87%

Aukščiausias 25 USD

Žemiausias 11 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių NeoGenomics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.